Top Markets
#1 Purr Purr +56.58%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +46.97%
#4 Non-Playable Coin Non-Playable Coin +29.18%
#5 StonkBroker StonkBroker +28.69%
#6 ApeX ApeX +25.25%
#7 Kinetiq Kinetiq +24.62%
#8 TENDIES TENDIES +24.06%
#9 Morpho Morpho +21.83%
#10 OriginTrail OriginTrail +21.30%
Coin of the day
Purr Purr
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Maxigen Biotech Inc. Maxigen Biotech Inc.

Maxigen Biotech Inc.

1783
Peringkat dalam Saham #21088
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development,... Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Harga Saham
$1.28
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$115.23M
Perubahan (1 hari)
-0.25%
Perubahan (1 tahun)
-10.17%
Negara
TW
Perdagangan Maxigen Biotech Inc. (1783)

Kategori

Healthcare
Rasio P/E untuk Maxigen Biotech Inc. (1783)
Rasio P/E per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Maxigen Biotech Inc., rasio P/E saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki rasio P/E sebesar 0.
Riwayat rasio P/E untuk Maxigen Biotech Inc. dari 2026 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 44.58 -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 30.10 -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 55.24 -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.